Home › Research › Inflammation and the immune system
Inhibition of Neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia
Jing Wu, Juanjuan Du, Ruinan Gu, Li Zhang, Xuechu Zhen, Yuanchao Li, Hongli Chen, Biao Jiang et al.. ChemMedChem, 2015-03-04
Topic: Inflammation, microglia and astrocytes
Plain-language summary
Androstene derivatives incorporating amino acid methyl esters were prepared, and their anti‐inflammatory effects were evaluated in lipopolysaccharide (LPS)‐activated BV‐2 microglial cells. Several compounds exhibited dose‐dependent inhibition. The most active compound, methyl ((3 S ,10 R ,13 S )‐3‐hydroxy‐10,13‐dimethyl‐2,3,4,7,8,9,10,11,12,13,14,15,16,17‐tetradecahydro‐1 H ‐cyclopenta[ a ]phenanthrene‐17‐carbonyl)‐ L ‐phenylalaninate ( 10 ) significantly suppressed LPS‐induced expression of inducible nitric oxide synthase (iNOS), cyclooxygenase‐2 (COX‐2), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α). Mechanistic studies revealed that compound 10 markedly inhibits phosphorylation of p38 mitogen‐activated protein kinases (MAPKs) and subsequent transcription factor (NF‐κB) and activator protein‐1 (AP‐1) activation. Furthermore, compound 10 decreased LPS‐activated microglial neurotoxicity in a condition medium/HT‐22 neuroblastoma co‐culture model. Taken together, these results suggest 10 is a potential lead compound for the development of a novel therapeutic agent for neurodegenerative diseases.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wu, J., Du, J., Gu, R., Zhang, L., Zhen, X., Li, Y., et al. (2015). Inhibition of Neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia. ChemMedChem. https://doi.org/10.1002/cmdc.201500027
Vancouver
Wu J, Du J, Gu R, Zhang L, Zhen X, Li Y, et al. Inhibition of Neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia. ChemMedChem. 2015. doi:10.1002/cmdc.201500027.
BibTeX
@article{wu2015-e6c5f580,
author = {Wu, Jing and Du, Juanjuan and Gu, Ruinan and Zhang, Li and Zhen, Xuechu and Li, Yuanchao and Chen, Hongli and Jiang, Biao and others},
title = {{Inhibition of Neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia}},
journal = {ChemMedChem},
year = {2015},
doi = {10.1002/cmdc.201500027},
url = {https://doi.org/10.1002/cmdc.201500027}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The most active compound, methyl ((3 S ,10 R ,13 S )‐3‐hydroxy‐10,13‐dimethyl‐2,3,4,7,8,9,10,11,12,13,14,15,16,17‐tetradecahydro‐1 H ‐cyclopenta[ a ]phenanthrene‐17‐carbonyl)‐ L ‐phenylalaninate ( 10 ) significantly suppressed LPS‐induced expression of inducible nitric oxide synthase (iNOS), cyclooxygenase‐2 (COX‐2), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α).
- Mechanistic studies revealed that compound 10 markedly inhibits phosphorylation of p38 mitogen‐activated protein kinases (MAPKs) and subsequent transcription factor (NF‐κB) and activator protein‐1 (AP‐1) activation.
- Taken together, these results suggest 10 is a potential lead compound for the development of a novel therapeutic agent for neurodegenerative diseases.
Study details
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 20 of the 56 points we could judge it on, which is 36 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (ChemMedChem) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 20 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 20 of the 56 points we could judge it on is 36 out of 100. |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Inflammation and the immune system from nearby years
Also tagged “plants”
117 studies in the library carry the topic tag “plants”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 117 tagged studies.